Study on symptoms of ethanol in breast cancer patients
Part of Cancer, Skin clinical trials.
This trial checks how breast cancer patients react to ethanol (alcohol) during chemotherapy with docetaxel. It aims to understand side effects and safety for people getting this treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have breast cancer confirmed by biopsy
- You need to be scheduled for chemotherapy with docetaxel that does not contain ethanol
- You must be willing to sign a consent form and follow the study procedures
- You cannot have any other cancer that might affect your breast cancer treatment
- You cannot have breast cancer that has spread to other parts of the body (Stage IV) or is at an early stage (Stage 0 or 1)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how often women with breast cancer experience changes in taste (called dysgeusia) while receiving chemotherapy. The goal is to better understand this side effect so doctors can help manage it.
This Phase 4 study tests an additional (adjuvant) treatment for breast cancer after surgery and standard follow-up care. It may help lower the chance the cancer comes back, but you must match specific tumor and body-chemistry requirements to join.
This Phase 3 trial studies different ways of giving common chemotherapy drugs (anthracyclines and taxanes) for locally advanced breast cancer that is HER2-negative. It aims to see which order or “sequencing” may work better for people like you.
This study looks at whether body fat and muscle (body composition) change how well certain chemotherapy works after surgery for early breast cancer. You may be considered if you are planned to receive docetaxel as adjuvant (after-surgery) chemotherapy and have recent CT scan images.
This study tests a new blood test to see if it can find tiny bits of tumor DNA after chemotherapy. If you have a larger or higher-risk breast cancer and are getting chemotherapy before surgery, you may join. The test could help doctors know if your cancer is gone or if more treatment is needed.
This study compares an “albumin-bound” form of paclitaxel versus other taxane chemotherapy options after breast surgery. It’s for people with HER2-negative, higher-risk breast cancer to see which approach works better in real-world care.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.